Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
Saved in:
| Title: | Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. |
|---|---|
| Authors: | Gebler C; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Lohoff T; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Paszkowski-Rogacz M; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Mircetic J; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Chakraborty D; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Camgoz A; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Hamann MV; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Theis M; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany., Thiede C; Medical Faculty Carl Gustav Carus, Medizinische Klinik und Poliklinik I, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany., Buchholz F; Affiliations of author: Medical Systems Biology, Medical Faculty Carl Gustav Carus, University cancer center, Technische Universitat Dresden, Dresden, Germany.; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; German Cancer Research Center, Heidelberg and German Cancer Consortium partner site Dresden, Germany.; National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2016 Aug 30; Vol. 109 (1). Date of Electronic Publication: 2016 Aug 30 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
